Preeclampsia, Diagnostics

Transparency Market Research United States of America United Kingdom

17.01.2023 - 20:32:46

Preeclampsia Diagnostics Market to Reach US$ 2.3 Billion by 2031: Studies Transparency Market Research, Inc.

Medtech companies' aim at increasing diagnostic accuracy of preeclampsia paves way to improved maternal and perinatal outcomes; high preference for blood tests to steer revenues Growing R&D spending on maternal health to reduce disease burden of specific hypertensive disorders of pregnancy, especially in North America; awareness of preeclampsia tests in Asia Pacific growingvalue stood at US$ 1.5 Bn in 2021.


Emerging prevalence and incidence trends of maternal hypertensive disorders has also influenced preeclampsia diagnosis criteria. Industry players making future analysis of preeclampsia diagnostics finds that wide adoption of blood and urine tests in patients will set the tone for timely diagnosis of preeclampsia. Furthermore, growing number of childbirths at hospitals and their focus on maternal and perinatal morbidity and mortality are enriching the value chain, find analysis of recent market trends.

Key Findings of Study

Advances in Preeclampsia Management Aim at Accurate Diagnostic Tests: Availability of various biochemical methods for the diagnosis of preeclampsia plays a pivotal role in its treatment. Thus, industry players are keen on developing and commercializing tests with better diagnostic accuracy. New technologies hold promising potential in reducing antenatal management of pre-eclampsia, and will expand the avenue for the firms in preeclampsia diagnostics market to tap into. Of note, demand for preeclampsia diagnosis and treatment in hospitals underpins vast revenue streams. Evidently, the hospital segment is poised for a promising CAGR from 2022 to 2031.

Global Initiatives to Lower Diseases Burden Spurring Demand for Tests: Worldwide, organizations are working concertedly to raise awareness of the mortality and morbidity caused by various hypertensive disorders of pregnancy. Stakeholders in the healthcare sector are leaning on maternal health improvements. Stridently, leading maternal health advocacy groups are committed toward addressing the risk of maternal death and fetal complications caused by various subtypes of preeclampsia. All these factors are reinforcing the industry size of preeclampsia diagnostics.

Request to Sample PDF of this Strategic Report (Use Corporate Mail ID for Top Priority):

Preeclampsia Diagnostics Market: Key Drivers

High global incidence of preeclampsia and its adverse impacts on maternal mortality is a key driver of the preeclampsia diagnostics market. Global initiatives undertaken by many healthcare organizations to promote programs for raising the awareness of the mortality and morbidity worldwide caused by severe hypertensive disorders of pregnancy are expanding avenues.

Growing R&D in the diagnosis of pre-eclampsia, in conjunction with advances in the recommendations by healthcare agencies on managing the diseases is a key underpinning of the market. Commercialization of advanced tests notably their accuracy has helped expand the prospects.

Regional Growth Dynamics

North America held a major share of the global market in 2021. The preeclampsia diagnostics market share of the region is driven by adoption of advanced management strategies. Furthermore, rapid adoption of medical interventions for reducing maternal hypertensive disorders will unlock promising prospects.

Asia Pacific was estimated to the fastest growing market in the same year. It is projected to advance at a CAGR of 4.4% from 2022 to 2031. The growth is fueled by rapid incidence of preeclampsia over the past few decades and rise in awareness of the morbidity and mortality. Furthermore, advances in maternal care will spur demand for accurate preeclampsia lab tests in the next few years.

Buy this Premium Research Report | Immediate Delivery Available –<ype=S

Preeclampsia Diagnostics Market: Competition Landscape

The global market is characterized by a consolidated competition landscape, with relatively few players accounting for a major share.

Some of the key market players are Danaher Corporation, Cardinal Health, Bio-Rad Laboratories, Inc., ARKRAY, Inc., DIRUI Industrial Co., Ltd., F. Hoffmann-La Roche Ltd., ACON Laboratories, Inc., and Abbott Laboratories.

Preeclampsia Diagnostics Market Segmentation

Test TypeBlood TestUrine TestOthersProduct & ServicesInstrumentsReagents & ConsumablesServicesEnd-userHospitalsDiagnostic CentersOthers

Regions Covered

North AmericasLatin AmericaEuropeLatin AmericaMiddle East & Africa

Ask for References – 

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

HIV/AIDS Diagnostics Market

Blood Testing Market

Dental Putty Market

Neurovascular Catheters Market

Non-Invasive Cancer Diagnostics Market

Cancer Diagnostics Market

Diagnostic Imaging Services Market

Diagnostic Reagents Market

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Nikhil Sawlani
Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453


Cision View original content: